Gender Identity Disparities in Cancer Screening Behaviors

Tabaac, Ariella R.; Sutter, Megan; Wall, Catherine S. J.; Baker, Kellan

doi:10.1016/j.amepre.2017.11.009

Cited by 140 publications

(102 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…While other research has found that transmasculine individuals are less likely than cisgender women to have been screened for cervical cancer, 2 we found that transmasculine individuals in our study, which included predominately white, insured, and college-educated participants, had a higher prevalence of Pap test use than US cisgender women (i.e., 69% in 2015). However, despite the elevated overall prevalence of Pap test use in our sample, our results suggest that gender identity disparities may exist among transmasculine people.…”

Section: Discussioncontrasting

confidence: 79%

Gender identity disparities in Pap test use in a sample of binary and non-binary transmasculine adults

et al. 2018

View full text Add to dashboard Cite

Section: Discussioncontrasting

confidence: 79%

Gender identity disparities in Pap test use in a sample of binary and non-binary transmasculine adults

et al. 2018

View full text Add to dashboard Cite

“…19 Another showed 84% for cisgender female patients and 69% among TM patients. 18 Notably, the rates of adherence exceed that of the rates accomplished here and suggest additional examination of barriers impeding access to cervical cancer screening for TM individuals at Mount Sinai.…”

Section: Discussionmentioning

confidence: 66%

“…9 Nationally, however, as many as one-third of all TM patients are not up-to-date with screening per U.S. clinical guidelines and TM individuals are more likely to have never undergone cervical cancer screening. 9,18,19 Among cisgender women, self-collected vaginal swabbing for hr-HPV testing as a primary method for cervical cancer screening has been found to be more acceptable than cervical cytological screening. 20,21 Selfcollection has led to improved rates of adherence to specified American College of Obstetricians and Gynecologists (ACOG) and Centers for Disease Control and Prevention (CDC) screening recommendations among historically under-screened women, suggesting that it could be used as a viable and less invasive screening option.…”

Section: Introductionmentioning

confidence: 99%

Improved Rates of Cervical Cancer Screening Among Transmasculine Patients Through Self-Collected Swabs for High-Risk Human Papillomavirus DNA Testing

et al. 2020

View full text Add to dashboard Cite

Introduction: Nearly all cervical cancer cases are caused by one of several high-risk strains of the human papillomavirus (hr-HPV). Transmasculine (TM) individuals (persons who have a masculine spectrum gender identity, but were recorded female at birth) have low adherence to standard cervical cancer screening modalities. Introduction of self-collected vaginal swabs for hr-HPV DNA testing may promote initiation and adherence to cervical cancer screening among TM individuals to narrow screening disparities. The purpose of this study was to assess the rate of cervical cancer screening among TM individuals following the introduction of self-collected swabbing for hr-HPV DNA testing in comparison to clinician-administered cervical specimen collection. Methods: Rates of uptake and adherence to cervical cancer screening among TM individuals were assessed before and after the clinical introduction of self-collected swab testing in October 2017. Rates were compared with the rates of cervical cancer screening among cisgender women at a colocated Comprehensive Health Program during the time period of review. Results: Of the 121 TM patients seen for primary care in the 6-month baseline period before the October 2017 introduction of self-collected swabbing for hr-HPV DNA testing, 30 (25%) had cervical cancer screening documented in the electronic medical record. Following the implementation of self-swabbing, of 193 patients, 98 (51%) had a documented cervical cancer screening, a twofold increase in the rates of adherence to cervical cancer screening (p < 0.001). Conclusion: Self-collected swab testing for hr-HPV can increase rates of adherence to screening recommendations among an otherwise under-screened population.

show abstract

“…7 Several studies indicate that transgender people may be less likely to use preventive care services, such as cervical and colon cancer screening. 32,33 In some cases transgender people face may face denial of coverage for preventive care services when a gender mismatch is perceived (e.g., cervical cytology for a transgender man). Compared with the general population, transgender people, especially transgender women of color, face significant psychosocial disparities, including higher rates of homelessness, unemployment, and poverty.…”

Section: Health Disparities For Transgender Peoplementioning

confidence: 99%

Addressing Needs of Transgender Patients: The Role of Family Physicians

Radix

2020

J Am Board Fam Med

View full text Add to dashboard Cite

There are approximately 1 million transgender and gender-diverse adults in the United States. Despite increased awareness and acceptance, they frequently encounter medical settings that are not welcoming and/or health care providers who are not knowledgeable about their health needs. Use of correct terminology, following best practices for name and pronoun use, and knowledge of gender-affirming interventions can create office environments that are welcoming to transgender clients. Health disparities faced by transgender patients that impact access to care include higher rates of mental health issues, substance use disorders, violence, and poverty. Transgender women are at greater risk for HIV acquisition and are less likely to achieve viral suppression compared with cisgender (nontransgender) individuals. Medical providers can facilitate HIV prevention efforts by offering pre-and postexposure prophylaxis to transgender patients at risk for HIV infection. Improving health outcomes requires attention to cultural competency and an understanding of lived experiences and priorities of transgender people.

show abstract

Gender Identity Disparities in Cancer Screening Behaviors

Cited by 140 publications

References 23 publications

Gender identity disparities in Pap test use in a sample of binary and non-binary transmasculine adults

Gender identity disparities in Pap test use in a sample of binary and non-binary transmasculine adults

Improved Rates of Cervical Cancer Screening Among Transmasculine Patients Through Self-Collected Swabs for High-Risk Human Papillomavirus DNA Testing

Addressing Needs of Transgender Patients: The Role of Family Physicians

Contact Info

Product

Resources

About